Immunoglobulin light chain amyloidosis (ALA) is a plasma cell dyscrasia characterized by deposition of amyloid fibrils in various organs and tissues. The current paper is devoted to clarify if ALA has a unique gene expression profile and to its pathogenetic argumentation. The meta-analysis of ALA patients vs. healthy donors, monoclonal gammopathy of undetermined significance, smoldering and multiple myeloma patients' cohorts have revealed molecular signature of ALA consists of 256 genes representing mostly ribosomal proteins and immunoglobulin regions. This signature appears pathogenetically supported and elucidates for the first time the role of ribosome dysfunction in ALA. In summary of our findings with literature overview, we hypothesize that ALA development is associated not only with changes in genes, coding amyloidogenic protein itself, but with post-transcriptional disbalance as well. Based on our data analysis in ALA, ribosome machinery is impaired and the affected link mainly involves translational initiation, elongation and co-translational protein folding.

Babak Myeloma Group Department of Pathological Physiology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Haematooncology Faculty of Medicine University of Ostrava Czech Republic

Department of Haematooncology University Hospital Ostrava Czech Republic

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc17013784

003      

CZ-PrNML

005      

20170502103842.0

007      

ta

008      

170413s2016 ne f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.gene.2016.06.017 $2 doi

035    __

$a (PubMed)27288311

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a ne

100    1_

$a Kryukov, Fedor $u Department of Haematooncology, Faculty of Medicine, University of Ostrava, Czech Republic; Department of Haematooncology, University Hospital Ostrava, Czech Republic. Electronic address: f.kryukov@gmail.com.

245    10

$a Does AL amyloidosis have a unique genomic profile? Gene expression profiling meta-analysis and literature overview / $c F. Kryukov, E. Kryukova, L. Brozova, Z. Kufova, J. Filipova, K. Growkova, T. Sevcikova, J. Jarkovsky, R. Hajek,

520    9_

$a Immunoglobulin light chain amyloidosis (ALA) is a plasma cell dyscrasia characterized by deposition of amyloid fibrils in various organs and tissues. The current paper is devoted to clarify if ALA has a unique gene expression profile and to its pathogenetic argumentation. The meta-analysis of ALA patients vs. healthy donors, monoclonal gammopathy of undetermined significance, smoldering and multiple myeloma patients' cohorts have revealed molecular signature of ALA consists of 256 genes representing mostly ribosomal proteins and immunoglobulin regions. This signature appears pathogenetically supported and elucidates for the first time the role of ribosome dysfunction in ALA. In summary of our findings with literature overview, we hypothesize that ALA development is associated not only with changes in genes, coding amyloidogenic protein itself, but with post-transcriptional disbalance as well. Based on our data analysis in ALA, ribosome machinery is impaired and the affected link mainly involves translational initiation, elongation and co-translational protein folding.

650    _2

$a amyloidóza $x genetika $7 D000686

650    _2

$a zvířata $7 D000818

650    _2

$a stanovení celkové genové exprese $7 D020869

650    12

$a geny pro lehké řetězce imunoglobulinů $7 D050439

650    _2

$a lidé $7 D006801

650    _2

$a paraproteinemie $x genetika $7 D010265

655    _2

$a dopisy $7 D016422

655    _2

$a metaanalýza $7 D017418

655    _2

$a přehledy $7 D016454

700    1_

$a Kryukova, Elena $u Department of Haematooncology, Faculty of Medicine, University of Ostrava, Czech Republic; Department of Haematooncology, University Hospital Ostrava, Czech Republic.

700    1_

$a Brozova, Lucie $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

700    1_

$a Kufova, Zuzana $u Department of Haematooncology, Faculty of Medicine, University of Ostrava, Czech Republic; Department of Haematooncology, University Hospital Ostrava, Czech Republic.

700    1_

$a Filipova, Jana $u Department of Haematooncology, Faculty of Medicine, University of Ostrava, Czech Republic.

700    1_

$a Growkova, Katerina $u Department of Haematooncology, Faculty of Medicine, University of Ostrava, Czech Republic.

700    1_

$a Sevcikova, Tereza $u Department of Haematooncology, Faculty of Medicine, University of Ostrava, Czech Republic; Department of Haematooncology, University Hospital Ostrava, Czech Republic.

700    1_

$a Jarkovsky, Jiri $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

700    1_

$a Hajek, Roman $u Department of Haematooncology, Faculty of Medicine, University of Ostrava, Czech Republic; Department of Haematooncology, University Hospital Ostrava, Czech Republic.

773    0_

$w MED00001888 $t Gene $x 1879-0038 $g Roč. 591, č. 2 (2016), s. 490-8

856    41

$u https://pubmed.ncbi.nlm.nih.gov/27288311 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20170413 $b ABA008

991    __

$a 20170502104209 $b ABA008

999    __

$a ok $b bmc $g 1200249 $s 974562

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2016 $b 591 $c 2 $d 490-8 $e 20160607 $i 1879-0038 $m Gene $n Gene $x MED00001888

GRA    __

$a NV15-29667A $p MZ0

LZP    __

$a Pubmed-20170413